
    
      A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine
      given by local injection at all the wound sites in patients undergoing urologic surgeries.
      Subjects of prospective study will be randomly divided using electronic program into two
      groups:

      The first group will receive intraoperative local Liposomal Bupivacaine injection at the port
      placement site. The control group will receive will local Marcaine (bupivacaine HCl)
      injection

      Primary Outcome Measures:

        -  Total opioid consumption measured in intravenous morphine equivalents dose during the
           postoperative hospital Stay

        -  Postoperative pain assessment using visual Analog Pain Scores & Brief Pain Inventory
           form.

        -  Length of Hospital Stay

        -  Time to First Opioid Use.

        -  Postoperative Constipation , paralytic ileus
    
  